ODAC to review Talon's Marqibo

FDA's Oncologic Drugs Advisory Committee will meet on March 21 to discuss an NDA from Talon Therapeutics Inc. (OTCBB:TLON) for Marqibo vincristine to treat Philadelphia chromosome-negative acute lymph...